SCHEMBL17082724

SCHEMBL17082724

C=CCC1CCC(C)[C@H]1CC(=O)O

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.32
▸ AKR1C4 P17516 1/20 0.32
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ SLC1A2 P43004 1/20 0.31
▸ THPO P40225 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ GRIK1 P39086 1/20 0.31
▸ GRM5 P41594 1/20 0.31
▸ GRIA1 P42261 1/20 0.31
▸ GRIA2 P42262 1/20 0.31
▸ GRIA3 P42263 1/20 0.31
▸ GRIA4 P48058 1/20 0.31
▸ BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1927992 0.77 HSD11B1 (0.44) HSD11B1MEN1KMT2AMAPK1TSHR
SCHEMBL8836934 0.73 GABRR1 (0.36) —
SCHEMBL5966273 0.72 TSHR (0.33) HSD11B1TSHRSLC6A12SLC6A11SLC6A13
SCHEMBL6427735 0.71 SLC6A12 (0.43) HSD11B1AKR1C4AKR1C3AKR1C2LMNA
SCHEMBL11556130 0.70 SLC6A12 (0.35) AKR1C4AKR1C3AKR1C2MEN1KMT2A
SCHEMBL2482028 0.70 MEN1 (0.32) MEN1KMT2AALDH1A1
SCHEMBL20142223 0.67 SLC6A12 (0.43) HSD11B1AKR1C4AKR1C3AKR1C2SLC6A12
SCHEMBL15544333 0.67 HSD11B1 (0.41) HSD11B1MEN1KMT2AMAPK1TSHR
SCHEMBL2848938 0.67 GABRR1 (0.38) HSD11B1SLC6A12SLC6A11SLC6A13
SCHEMBL9406866 0.66 ANPEP (0.43) KMT2AALDH1A1LMNASLC6A12SLC6A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054368-B1 CYCLIC 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-09-16 — — EP disclosed
Send feedback